Rational design and synthesis of bioactive miPEP205-derived fragments as modulators of Wnt/β-catenin signaling in triple-negative breast cancer
Year: 2026
Type: conference-paper
Abstract: Triple-Negative Breast Cancer (TNBC) is the most aggressive breast cancer subtype, accounting for 15 to 20% of cases and showing poor survival outcomes despite chemotherapy, largely due to tumor relapse and an immunosuppressive microenvironment [1].These limitations highlight the necessity for new molecular targets.miPEP205, a 49-aminoacid micropeptide encoded by MIR205HG, acts as a negative regulator of the canonical Wnt/β-catenin pathway, a key driver of TNBC progression.By interacting with GSK-3β, miPEP205 promotes β-catenin phosphorylation and degradation, ultimately reducing tumor cell proliferation [2].
Source: European Peptide Symposium (EPS)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7212401993
